Major players operating in the worldwide STD diagnostics market comprise Abbott Laboratories, Roche Holdings AG, Hologic Inc., Becton Dickinson and Company, Affymetrix, Danaher Corporation, Cepheid Inc., bioMerieux, DiaSorin, Alere Inc., and Orasure. These players are set to unlock new gates for the development of STD diagnostics market.
As per analysts at Zion Market Research, the global STD diagnostics market added up for almost USD 103.20 Billion in 2015 and is likely to cross almost USD 166.50 by end of 2021, developing at a CAGR of almost 8.3% from 2015 to 2021.
Rising Occurrence Of Weakened Immune System To Boost The STD Diagnostics Market
As per analysts at Zion Market Research, the STD diagnostics market was likely to see the highest development in the years to come due to rising percentage of HIV/HPV infected people all over the world. In addition to this, rising occurrence of weakened immune system paired with unsafe sex is also believed as a major driving reason that promotes sexually transmitted diseases and hence indirectly benefits the STD diagnostics market. Furthermore, rising demand for accurate and rapid diagnostic tests and attendance of favorable government programs for STD testing in emerging nations such as India, Brazil, and China are additionally claimed to propel the growth of STD diagnostics market.
On the other hand, the high price of diagnostic test is believed as a primary limiting factor that will hamper the development of STD diagnostics market. In addition to this, the discontinuation of therapy and reluctance of the infected population paired with the psychological effect of sexual transmitted are also believed as a major restraining factor that might hinder the development of STD diagnostics market.
Request Free Sample Research Report @ https://www.zionmarketresearch.com/sample/std-diagnostics-market
New R&D activities by government and academic bodies are also set to drive the STD diagnostics market. For instance, in July 2018, a group of researchers have established a new defense against the virus that causes AIDS, HIV-1. The team employed an animal model to demonstrate that an antibody dubbed as IgM (Immunoglobulin M) was effective in stopping infection after exposure to mucosal AIDS virus.
Accessibility Of Technologically Enhanced Computer-Directed Screening Tests Led To The Growth Of STD Diagnostics Market In North America
Area-wise, North America was the dominating area for STD diagnostics market in 2015 in terms of income owing to the accessibility of technologically enhanced computer-directed screening tests. Europe and North America has the high occurrence of P&S Syphilis, Chlamydia, and Gonorrhea and holds the biggest share for testing in this region for these infections. In addition to this, lifestyle-associated factors such as having several sex partners, is very ordinary in European nations and the U.S. This led to the rise in the occurrence of sexually transmitted infection boosting the STD diagnostics market.